The NY Times has another article in its series on Suboxone. Buprenorphine was developed as a safer alternative to methadone for treating heroin and painkiller addiction, a take-home medication that could be prescribed by doctors in offices rather than dispensed daily in clinics. But in some areas a de facto clinic scene, unregulated, … Continue reading “a hopeless disease”
Tag: buprenorphine
Addiction Treatment With a Dark Side
The NY Times has a new piece on Suboxone. First, on its blockbuster status: Suboxone is the blockbuster drug most people have never heard of. Surpassing well-known medications like Viagra and Adderall, it generated $1.55 billion in United States sales last year, its success fueled by an exploding opioid abuse epidemic and the embrace of federal officials … Continue reading Addiction Treatment With a Dark Side
Suboxone diversion?
A recent study looking at diversion of buprenorphine finds that: While 9% reported recent street-obtained buprenorphine use, only a small minority reported using buprenorphine to get high, with the majority reporting use to manage withdrawal symptoms. The use of street-obtained buprenorphine primarily to avoid withdrawal fits with Dawn Farm's experience, though the percentage would be … Continue reading Suboxone diversion?
Buprenorphine compliance rates
The following abstract popped up today. The purpose of the study was to look at factors associated with completion of the 6 month, primary care based program. What struck me was the completion rate--35.7%. For all the crowing about ORT, this seems really low. (And, they said this completion rate is consistent with prior studies.) … Continue reading Buprenorphine compliance rates
Buprenorphine and emotional reactivity
The following article was shared with me by a reader. Not surprisingly, the emphasized portion below caught my eye. [emphasis mine] Abstract Addictions to illicit drugs are among the nation’s most critical public health and societal problems. The current opioid prescription epidemic and the need for buprenorphine/naloxone (Suboxone®; SUBX) as an opioid maintenance substance, and its … Continue reading Buprenorphine and emotional reactivity
Not available?
Another study finds no benefit from cognitive behavioral therapy and contingency management with opiate replacement treatment. [CORRECTED: See below] Background and aims The Controlled Substances Act requires physicians in the United States to provide or refer to behavioral treatment when treating opioid-dependent individuals with buprenorphine; however no research has examined the combination of buprenorphine with … Continue reading Not available?
The spirituality of addiction treatment
I was listening to On Being this morning and was struck by this one quote. I think this could be paraphrased into something that fits perfectly with why we have such great staff who put so much ourselves into our work here: For me, thinking about living in a city like Chicago where you just … Continue reading The spirituality of addiction treatment
2012′s most popular posts #3 – Hazelden to start opioid maintenance
This has gotten a lot of attention [emphasis mine]: ...for the first time, Hazelden will begin providing medication-assisted treatment for people hooked on heroin or opioid painkillers, starting at its Center City, Minnesota facility and expanding across its treatment network in five states in 2013. This so-called maintenance therapy differs from simply detoxifying addicts until … Continue reading 2012′s most popular posts #3 – Hazelden to start opioid maintenance
2012′s most popular posts #8 – Another Reaction to Hazelden’s Adoption of Suboxone
Mark Willenbring, a former Director of the Treatment and Recovery Research Division of the National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health weighs in on Hazelden's embrace of Suboxone Hazelden's new approach is a seismic shift that is likely to move the entire industry in this direction. I told Marv that it was like … Continue reading 2012′s most popular posts #8 – Another Reaction to Hazelden’s Adoption of Suboxone
Lines are being drawn
A major treatment provider, Caron, weighs in on Hazelden's adoption of buprenorphine maintenance treatment: We use buprenorphine (Suboxone) to assist with the detoxification process from opioids and the length of time can vary depending on the patient’s progress and additional medical issues, such as chronic pain. However, unlike Hazelden’s goal as stated in … Continue reading Lines are being drawn
Recovery Review 